๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial register · China

Chronic Obstructive Pulmonary Disease (COPD) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 8 Beijing 8 Chengdu 5 Changsha 4 Changchun 3
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou8 Beijing8 Chengdu5 Changsha4 Changchun3
All 40 locations
Target enrolment
to

Chronic Obstructive Pulmonary Disease (COPD) trials in China

23 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
cfMSC Stem Cell Therapy Targeting COPD
NCT07477600Chronic Obstructive Pulmonary Disease (COPD)
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Cross-Regional Unmanned Aircraft Transport of Donor Lungs
NCT07790822Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), End-stage Lung Disease
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
25
Guangzhou
2026-09-01
Not yet open
High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease
NCT07791979Hypoxemia, Gastric Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Esophageal Cancer
Zhejiang University
Not applicable
90
Hangzhou
2026-08-29
Not yet open
TCM Cohort for Elderly COPD
NCT07780682Chronic Obstructive Pulmonary Disease (COPD)
Henan University of Traditional Chinese Medicine
Observational
2,386
Zhengzhou
2026-08-20
Not yet open
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
NCT07665359Chronic Obstructive Pulmonary Disease (COPD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
630
Guangzhou, Wuhan, Nanchang, Shanghai, Chengdu, Hangzhou, Huzhou, Jiaxing
2026-07-01
Recruiting
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
NCT07355868Chronic Obstructive Pulmonary Disease (COPD)
Regend Therapeutics
Phase EARLY_PHASE1
12
Yiwu
2026-03-19
Recruiting
IMPACT COPD Cohort (China)
NCT07382986Chronic Obstructive Pulmonary Disease (COPD), Multimorbidities
Beijing Chao Yang Hospital
Observational
10,000
Hebi, Tongliao, Mianyang, Shihezi
2026-02-26
Active, closed
AI-Powered Sound Analysis for COPD Screening
NCT07457073Chronic Obstructive Pulmonary Disease (COPD)
Sir Run Run Shaw Hospital
Observational
3,000
Hangzhou
2026-02-23
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07288554Chronic Obstructive Pulmonary Disease (COPD)
DrugBBT002
Bambusa Therapeutics
Phase 1
68
Hefei, Guangzhou, Jiangmen, Qingyuan, Xinxiang, Yichang, Xuzhou, Nanchang
2025-09-05
Active, closed
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07108699Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
180
Chengdu
2025-08-13
Recruiting
Immune Status and Disease Control of Inflammatory Airway Diseases
NCT07493629Airway Inflammation, Chronic Obstructive Pulmonary Disease (COPD), Asthma (Diagnosis), Bronchiectasis
First Affiliated Hospital of Ningbo University
Observational
200
Ningbo
2025-08-01
Recruiting
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07292714Chronic Obstructive Pulmonary Disease COPD
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2
360
Chizhou, Hefei, Lanzhou, Huizhou, Jiangmen, Qingyuan, Zunyi, Langfang
2025-07-15
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca
Phase 2
987
Baotou, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-06-27
Active, closed
Shared Medical Appointment for COPD Patients (SMA-COPD)
NCT07128745Chronic Obstructive Pulmonary Disease, COPD
Peking University Third Hospital
Not applicable
280
Beijing
2025-06-05
Recruiting
Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases
NCT07472738Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases
Beijing Chao Yang Hospital
Observational
950
Beijing
2025-05-07
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
NCT06946953Chronic Obstructive Pulmonary Disease (COPD)
Ruijin Hospital
Phase 1/2
20
Qionghai, Shanghai
2025-03-23
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca
Phase 3
990
Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-03-18
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
By invitation
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion
NCT06820749Asthma Bronchiale, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
309
Beijing
2024-12-10
Recruiting
Exploring the Diagnostic Performance of Dynamic Chest Radiology in Chronic Obstructive Pulmonary Disease
NCT06653413Chronic Obstructive Pulmonary Disease (COPD)
Nanfang Hospital, Southern Medical University
Observational
2,500
Guangzhou
2024-01-01
Recruiting
A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease
NCT07382258Chronic Obstructive Pulmonary Disease (COPD)
Novlead Inc.
Not applicable
16
Nanjing
2023-05-17
Active, closed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
NCT05595642Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche
Phase 3
1,290
Guangzhou, Zhanjiang, Zunyi, Lianyungang, Beijing, Changchun, Changsha, Chengdu
2022-12-29
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/chronic-obstructive-pulmonary-disease-copd

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies listing the condition Chronic Obstructive Pulmonary Disease (COPD).

How many Chronic Obstructive Pulmonary Disease (COPD) trials are recruiting in China?

12 of the 23 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chronic Obstructive Pulmonary Disease (COPD)), 23 studies
PhaseStudiesRecruitingShare
Observational7530.4%
Not applicable5121.7%
Phase 24217.4%
Phase 1218.7%
Phase 1/2218.7%
Phase 3218.7%
Phase EARLY_PHASE1114.3%

Most active sponsors

Lead sponsors with the most studies (Chronic Obstructive Pulmonary Disease (COPD))
Lead sponsorStudiesRecruiting
AstraZeneca22
Beijing Chao Yang Hospital22
Haisco Pharmaceutical Group Co., Ltd.20
Bambusa Therapeutics11
China-Japan Friendship Hospital11
First Affiliated Hospital of Ningbo University11
Henan University of Traditional Chinese Medicine10
Hoffmann-La Roche10
Mabwell (Shanghai) Bioscience Co., Ltd.11
Nanfang Hospital, Southern Medical University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.